Its expression in cervical adenocarcinoma was significantly higher than that in the normal glandular epithelium, but there was no significant difference between cervical squamous cell carcinoma and normal squamous epithelium, suggesting that AHNAK2 may be a potential biomarker of cervical adenocarcinoma. The gene discussed is AHNAK2; the disease is cervical squamous cell carcinoma.